Revenue
No reported data
Curanex Pharmaceuticals Inc (CURX)
Price—Loading quote
Net income
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Research & development | $3.0M | — |
| Operating expenses | $4.2M | $365,062 |
| Operating income | −$4.2M | −$365,062 |
| Net income | −$4.2M | −$361,506 |
| Basic EPSper diluted share | -$0.17 | -$0.03 |
| Diluted EPSper diluted share | -$0.17 | -$0.03 |